Patents are pending so not strong. But, this link explains, with reference to the prospectus, that there is an organization involved with executing the patent on behalf of LTP. https://www.livewiremarkets.com/wires/ltr-pharma-ed-the-need-for-speed
hence, I would expect the patents to executed when the time is right to maximize their duration. In saying this, market exclusivity would be 3 years likely in USA and patents last much longer than this, so probably not too impactful by the time end of exclusivity arrives
Ann: SPONTAN achieves positive clinical study results, page-24
-
- There are more pages in this discussion • 155 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
78.0¢ |
Change
-0.010(1.27%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 80.0¢ | 81.0¢ | 75.0¢ | $296.4K | 380.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.5¢ | 2873 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| LTP (ASX) Chart |